Skip to main content

Advertisement

Table 2 Conditions of definitive screening designed experiments

From: The development of an herbal material quality control strategy considering the effects of manufacturing processes

No. Panax notoginseng X1 (v/v %) X2 (h) X3 (mL) X4 (mL) X5 (mL) X6 (BV/h) X7 (BV/h) X8 (BV) X9 (v/v %) X10 (min)
1 PN12 85 10.0 1000 200 500 2.0 2.0 3.0 65 180
2 PN7 85 6.0 600 100 300 1.0 1.0 1.0 55 120
3 PN10 90 8.0 1000 100 500 2.0 1.0 1.0 55 120
4 PN2 80 8.0 600 200 300 1.0 2.0 3.0 65 180
5 PN15 90 10.0 800 200 300 2.0 2.0 1.0 55 120
6 PN3 80 6.0 800 100 500 1.0 1.0 3.0 65 180
7 PN11 90 6.0 1000 150 500 1.0 2.0 3.0 55 120
8 PN10 80 10.0 600 150 300 2.0 1.0 1.0 65 180
9 PN8 90 10.0 600 200 400 2.0 1.0 3.0 65 120
10 PN11 80 6.0 1000 100 400 1.0 2.0 1.0 55 180
11 PN12 90 10.0 1000 100 500 1.5 2.0 1.0 65 180
12 PN14 80 6.0 600 200 300 1.5 1.0 3.0 55 120
13 PN4 90 6.0 1000 200 300 2.0 1.5 3.0 55 180
14 PN9 80 10.0 600 100 500 1.0 1.5 1.0 65 120
15 PN6 90 6.0 600 200 500 1.0 2.0 2.0 65 120
16 PN8 80 10.0 1000 100 300 2.0 1.0 2.0 55 180
17 PN2 90 6.0 600 100 500 2.0 1.0 3.0 60 180
18 PN16 80 10.0 1000 200 300 1.0 2.0 1.0 60 120
19 PN5 90 6.0 600 100 300 2.0 2.0 1.0 65 150
20 PN6 80 10.0 1000 200 500 1.0 1.0 3.0 55 150
21 PN1 90 10.0 600 100 300 1.0 2.0 3.0 55 180
22 PN4 80 6.0 1000 200 500 2.0 1.0 1.0 65 120
23 PN16 90 10.0 1000 100 300 1.0 1.0 3.0 65 120
24 PN15 80 6.0 600 200 500 2.0 2.0 1.0 55 180
25 PN13 90 6.0 1000 200 300 1.0 1.0 1.0 65 180
26 PN7 80 10.0 600 100 500 2.0 2.0 3.0 55 120
27 PN3 90 10.0 600 200 500 1.0 1.0 1.0 55 180
28 PN13 80 6.0 1000 100 300 2.0 2.0 3.0 65 120
29 PN9 85 8.0 800 150 400 1.5 1.5 2.0 60 150
30 PN14 85 8.0 800 150 400 1.5 1.5 2.0 60 150
31 PN5 85 8.0 800 150 400 1.5 1.5 2.0 60 150
32 PN1 85 8.0 800 150 400 1.5 1.5 2.0 60 150